123
Effective for combating obesity, treating diabetes and potentially also for reducing inflammation, including brain inflammation, responsible for pathologies that are currently irreversible, such as Parkinson’s and Alzheimer’s. These are the latest generation incretin-mimetic, antidiabetic and anti-obesity drugs, which according to an article by Nature – which refers to the latest pre-clinical and clinical studies – can have an important role in reducing the inflammatory processes that affect various organs, such as the liver, kidneys, heart and even the brain: it is precisely this characteristic that makes these molecules potentially usable in the treatment of the two fearful neurodegenerative diseases that affect the nervous system.